UBE2W expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.188400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.293000E-01
Normal-vs-Stage2
7.439600E-01
Normal-vs-Stage3
7.692600E-01
Normal-vs-Stage4
3.717000E-01
Stage1-vs-Stage2
8.602200E-01
Stage1-vs-Stage3
4.169400E-01
Stage1-vs-Stage4
4.274200E-01
Stage2-vs-Stage3
4.864600E-01
Stage2-vs-Stage4
2.257000E-01
Stage3-vs-Stage4
2.434200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.178200E-01
Normal-vs-AfricanAmerican
7.106000E-01
Normal-vs-Asian
8.310000E-01
Caucasian-vs-AfricanAmerican
8.339200E-01
Caucasian-vs-Asian
2.698600E-01
AfricanAmerican-vs-Asian
4.454200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.252000E-01
Normal-vs-Female
6.936400E-01
Male-vs-Female
8.459800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.554400E-01
Normal-vs-Age(41-60Yrs)
4.460000E-01
Normal-vs-Age(61-80Yrs)
8.544000E-01
Normal-vs-Age(81-100Yrs)
9.204600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.225600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.485800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.090200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.735860E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.096840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.065400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.250600E-01
Normal-vs-Daily Drinker
9.910400E-01
Normal-vs-Weekly Drinker
6.939600E-01
Normal-vs-Occasional Drinker
3.593800E-01
Normal-vs-Social Drinker
8.160800E-01
Non Drinker-vs-Daily Drinker
8.569400E-01
Non Drinker-vs-Weekly Drinker
5.240200E-01
Non Drinker-vs-Occasional Drinker
2.934100E-02
Non Drinker-vs-Social Drinker
5.369600E-01
Daily Drinker-vs-Weekly Drinker
5.472400E-01
Daily Drinker-vs-Occasional Drinker
4.366000E-02
Daily Drinker-vs-Social Drinker
6.684200E-01
Weekly Drinker-vs-Occasional Drinker
1.830250E-02
Weekly Drinker-vs-Social Drinker
3.420200E-01
Occasional Drinker-vs-Social Drinker
1.578250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.794820E-01
Normal-vs-Grade 2
6.786000E-02
Normal-vs-Grade 3
7.538000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.749200E-01
Grade 1-vs-Grade 3
4.210000E-01
Grade 1-vs-Grade 4
1.794820E-01
Grade 2-vs-Grade 3
5.045800E-01
Grade 2-vs-Grade 4
6.786000E-02
Grade 3-vs-Grade 4
7.538000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.779200E-01
Normal-vs-NonDiabetic
8.086600E-01
Diabetic-vs-NonDiabetic
7.284400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.207400E-01
Normal-vs-NoPancreatitis
7.531200E-01
Pancreatitis-vs-NoPancreatitis
4.416000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.545600E-01
Normal-vs-N1
6.896600E-01
N0-vs-N1
8.882600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.548000E-01
Normal-vs-TP53-NonMutant
9.246800E-01
TP53-Mutant-vs-TP53-NonMutant
1.399800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
